Joint ActionSHIELD

Joint Action-EU4HEALTH “Strategies for health interventions aimed at eliminating infection-related cancer” (SHIELD Project)

 

The overall aim of the Joint Action “Strategies for Health Interventions to Eliminate Infection related Cancer” (SHIELD) is to decrease premature morbidity and mortality caused by communicable diseases, in particular cancers caused by infections and vaccine-preventable cancers. 

Combining different strategies into a comprehensive and effective prevention programme requires coordination among multiple and diverse stakeholders, including civil societies, public health authorities and institutions, social support structures, health systems and health scientists. 

A key focus will be on identifying and addressing possible structural and individual barriers preventing optimal programme performance and on identifying/developing and transferring/implementing promising practices. SHIELD aims to devise such an effective programme across the European continent by combining different complementary competencies that have worked within this area previously. 

The project addresses the priorities of the call by investigating how to make sure that all relevant preventive measures are being implemented at scale in different countries and identifying the barriers hampering implementation – both at structural and individual levels, and with a strong focus on the roles that stigma and discrimination play, particularly for HIV but also for other infections. 

Through application of modelling work, SHIELD also seeks to determine the optimal mix of preventive measures to be implemented in different countries and settings. The starting point is to do this across all primary, secondary, and tertiary preventive measures, rather than only focusing on vaccination coverage, to increase the impact of the available prevention options on decreasing cancers caused by infections.

The SHIELD Consortium consists of 69 partners (31 BEN, 36 AE, 2 AP) from 25 European countries, 21 are Member States (DK, BE, HR, CY, CZ, EE, FI, FR, DE, EL, HU, IT, LV, LT, MT, NL, PL, PT, RO, ES, SE) and the additional 4 are BA, MD, NO, UA

The DGSPyES is leading the work on stigma and discrimination within work package 5, which aims to evaluate national biomedical prevention programs (including integrated diagnostic and vaccination strategies) and implement measures to combat stigma and discrimination associated with HIV, viral hepatitis, tuberculosis, and STIs.

Coordinator's contact information:
CHIP, Rigshospitalet, Dinamarca; shield.rigshospitalet@regionh.dk

Partners:

1. Denmark - Capital Region of Denmark (RH/CHIP)

        Affiliated entities: RH/CHIP will engage with 4 AEs The Region of Southern Denmark (RSYD), Statens Serum Institut (SSI) & Central Denmark Region, Aarhus University Hospital AUH) and Sundhedsstyrelsen (SST)

2. Belgium - Sciensano (SCI)

3. Affiliated entities: Sciensano will engage with 2 AEs University on Antwerp (UA)  and Vlaanderen – Department Zorg (BE-Dep. Zorg VL)

3. Bosnia and Herzegovina - PHI University Clinical Center of Republika Srpska (UKC RS)
4. Croatia - Croatian Institute of Public Health (CIPH)

   Affiliated entities: HZJZ will engage with 3 AEs Teaching Institute of Public Health of Split and Dalmatian County (TIPH SDC), Andrija Stampar Teaching Institute of Public Health (ASTIPH), Public Health Institute od Dubrovnik-Neretva County (PHi Dubrovnik)

5. Cyprus - Department of Medical and Public Health Services of the Ministry of Health Cyprus (MPHS)

    Affiliated entities: MPHS will engage with 1 AE Cyprus University of Technology (CUT)

6. Czechia - The National institute of Public Health (SZÚ)
7. Estonia - National Institute for Health Development (TAI)

   Affiliated entities: TAI will engage with 2 AEs Estonian Health Board (EHB) and University of Tartu (UniTartu)

8. France – INSERM (INSERM)
9. France - Ministère de la Santé et de l'accès aux soins (DGS)
10. Finnish Institute of Health and Welfare (THL)
11. Germany - Federal Institute of Public Health (BIÖG)
12. Germany – Robert Koch Institute (RKI)
13. Greece - Ethnikos Organismos Dimosias Ygeias (National Public Health Organisation, EODY)

    Affiliated entities: EODY will engage with 1 AE National and Kapodistrian University of Athens (NKUA)

14. Hungary - National Directorate General for Hospitals (NDGH/OKFO)

    Affiliated entities: NDGH/OKFO will engage with 1 AE National Center for Public Health and Pharmacy (NNGYK)

15. Italy – Istituto Superiore di Sanità (ISS)

Affiliated entities: ISS will engage with 12 AEs Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo (UNIPA), Università degli Studi di Padova – Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche (UNIPD), University of Cassino and Southern Lazio (UNICLAM), IRCCS Azienda Ospedaliero-Universitaria di Bologna (IRCCS AOUBO), University of Naples Federico II, Department of Clinical Medicine and Surgery (UNINA), Sapienza - University of Rome, Department of Public Health and Infectious Diseases (UNIROMA1),   Regione Liguria (Reg Lig), University of Pisa (UNIPI), Università Cattolica del Sacro Cuore (UCSC), Azienda Unita Sanitaria Locale Di Reggio Emilia (AUSL RE), Istituto per lo studio, la prevenzione e la rete oncologica (ISPRO), Regione Lombardia (Reg Lom)

16. Latvia - Riga Stradins University (RSU)
17. Lithuania – Ministry of health of the Republic of Lithuania (SAM LT)

18. Affiliated entities: SAM LT will engage with 1 AE National Public Health Center (NVSC)

18. Lithuania - Vilnius University Faculty of Medicine (VU)
19. Malta – Ministry for Health and Active agening (MHA)
20. Moldova – National Agency for Public Health (NAPH)
21. Netherlands - Amsterdam Universitair Medisch Centrum (AUMC)
22. Norway - Norwegian Institute of Public Health (NIPH)
23. Poland - National Institute of Public Health NIH - National Research Institute (NIPH NIH – NRI)
24. Romania – National Institute of Public Health (NIPH)
25. Spain Institut Català d’Oncologia (ICO)
    Affiliated entities: ICOwill engage with 2 AEs Universitat de Barcelona (UB), Secretariat for Public Health/Public Health Agency of Catalonia (GENCAT)
26. Spain - Dirección General de Salud Pública y Equidad en Salud del Ministerio de Sanidad de España (DGSPyES)

    Affiliated entities: DGSPyESwill engage with 1 AE Fundación CSAI (FCSAI)

27. Sweden - Folkhälsomyndigheten / Public Health Agency of Sweden (PHAS)

    Affiliated entities: PHASwill engage with 4 AE Socialstyrelsen/The National Board of Health and Welfare (SoS), Karolinska Instituttet (KI), Region Stockholm/Karolinska University Hospital (Reg Sto), Region Uppsala / Uppsala Akademiska Sjukhus      (REG UPS)

28. Ukraine - Public Health Center of the Ministry of Health of Ukraine (PHC)
29. Ukraine - National Cancer institute of the Ministry of Health of Ukraine (NCI)
30. Bosnia and Herzegovina - Institute for Public Health of the Federation of Bosnia and Herzegovina (PHI-FBIH)
31. Portugal – Directorate_General of Health (DGS)

        Affiliated entities: DGS will engage with 2 AEs Instituto de Saúde Pública da Universidade do Porto (ISPUP) and Unidade Local de Saúde de Santo António (ULSSA)

Associated Partners: 

32. Italy- University of Florence (UniFi)
33. Bosnia and Herzegovina – The Ministry of Health and Social Welfare of Republika Srpska (MoH SRPSKA)

Declaración de financiación:

“Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HaDEA. Neither the European Union nor the granting authority can be held responsible for them.”